|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0026844,
umls-concept:C0052360,
umls-concept:C0086418,
umls-concept:C0205177,
umls-concept:C0205531,
umls-concept:C0226896,
umls-concept:C0231491,
umls-concept:C0442027,
umls-concept:C1135918,
umls-concept:C1173227,
umls-concept:C1280500,
umls-concept:C1527415
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2002-8-26
|
|
pubmed:abstractText |
To investigate the effects of YM471, a non-peptide arginine vasopressin (AVP) V1A and V2 receptor antagonist, on the AVP-induced growth responses in human vascular smooth muscle cells (VSMCs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1807-14
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:12195123-Aorta,
pubmed-meshheading:12195123-Arginine Vasopressin,
pubmed-meshheading:12195123-Azepines,
pubmed-meshheading:12195123-Cells, Cultured,
pubmed-meshheading:12195123-Enzyme Activation,
pubmed-meshheading:12195123-Humans,
pubmed-meshheading:12195123-Hyperplasia,
pubmed-meshheading:12195123-Hypertrophy,
pubmed-meshheading:12195123-Mitogen-Activated Protein Kinases,
pubmed-meshheading:12195123-Muscle, Smooth, Vascular,
pubmed-meshheading:12195123-Piperidines,
pubmed-meshheading:12195123-Receptors, Vasopressin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Effect of YM471, an orally active non-peptide arginine vasopressin receptor antagonist, on human vascular smooth muscle cells.
|
|
pubmed:affiliation |
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd, Tsukuba, Ibaraki, Japan. tahara@yamanouchi.co.jp
|
|
pubmed:publicationType |
Journal Article
|
